Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $63.6 million.

  • Haemonetics' Other Non-Current Liabilities fell 2929.95% to $63.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $63.6 million, marking a year-over-year decrease of 2929.95%. This contributed to the annual value of $68.2 million for FY2025, which is 912.43% down from last year.
  • As of Q4 2025, Haemonetics' Other Non-Current Liabilities stood at $63.6 million, which was down 2929.95% from $66.1 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Other Non-Current Liabilities registered a high of $100.3 million during Q2 2021, and its lowest value of $63.6 million during Q4 2025.
  • For the 5-year period, Haemonetics' Other Non-Current Liabilities averaged around $79.6 million, with its median value being $77.2 million (2022).
  • As far as peak fluctuations go, Haemonetics' Other Non-Current Liabilities skyrocketed by 2871.4% in 2024, and later plummeted by 2929.95% in 2025.
  • Haemonetics' Other Non-Current Liabilities (Quarter) stood at $91.9 million in 2021, then fell by 14.85% to $78.2 million in 2022, then dropped by 2.51% to $76.3 million in 2023, then grew by 17.97% to $90.0 million in 2024, then dropped by 29.3% to $63.6 million in 2025.
  • Its Other Non-Current Liabilities stands at $63.6 million for Q4 2025, versus $66.1 million for Q3 2025 and $68.1 million for Q2 2025.